The synthesis of new biologically active substances among 4-amino-5-alkyl-1,2,4-triazole(4H)-3-yl-thioacetanilides and their chemical modification
DOI:
https://doi.org/10.24959/nphj.15.2049Keywords:
3-mercapto-4-amino-5-alkyl-1, 2, 4-triazole, derivatives, synthesis, alkylation, Paal-Knorr reaction, antitumor activityAbstract
The synthesis of a series of new 4-amino-5-alkyl-1,2,4-triazole(4H)-3-yl thioacetanilides and 4-pyrrolyl-5-alkyl-1,2,4-triazole(4H)-3-yl thioacetanilides has been described in the article. The key intermediates – 4-amino-5-alkyl-3-mercapto-1,2,4-triazoles(4H) 4a-c were synthesized started from the corresponding carboxylic acids (acetic, propanoic and butanoic) after their esterification followed by hydrazinolysis, CS2 reaction and cyclisation under hydrazine hydrate. The first group of substances 6a-p was obtained by alkylation of the key intermediate 4a-c with chloroacetic acid anilides in the presence of basic catalysts. The subsequent modification under conditions of Paal-Knorr reaction led to the corresponding pyrrolyl derivatives 7a-p. The structure of the compounds synthesized has been proven by the data of elemental analysis and NMR spectra. In NMR-spectra the result of alkylation has been confirmed by disappearance of the chemical shift of the mercapto group. All compounds both intermediate 4a-c and end products 6a-u and 7a-u contain signals of the alkyl protons of substituents in the triazole (methyl or methyl and methylene) ring; the 4-aminogroup protons are in the spectra of compounds 6 as singlet signals at 5.87-5.92 ppm. Modification of amino derivatives 6 into pyrrolyl substituted 7 is accompanied with the appearance of the characteristic signals of methyne protons of the pyrrole moiety instead of the signal of the amino group – triplet (positions 3,4) at 6.30-6.31 ppm and doublet (positions 2,5) at 7.21-7.24 ppm. Substances 7a, 7f, 7j and 7m were tested on the antitumour activity in vitro. As the result of this investigation it was noted that unfortunately all substances selected were not effective inhibitors of tumour cells in this dose.References
Саидов Н.Б., Георгиянц В.А. // Фармация. – 2014. – №2. – С. 12-14.
Саїдов Н.Б., Георгіянц В.А., Ліпакова К.Ю. // Фармац. часопис. – 2014. – С. 15-18.
Akhter M.W., Hassan M.Z., Amir M. // Arab. J. Chem. – 2014. – Vol. 7, №9. – Р. 955-963.
Anu Vipan K.K., Bhawana S., Prabhakar K.V. // Res. J. Pharm., Biol., Chem. Sci. – 2014. – Vol. 5, №6. – P. 866-872.
Ayah A.H., Firas H. // Int. J. Appl. Sci. Tech. – 2014. – Vol. 4, №2. – Р. 202-211.
Chandrashekar A., Eswarappa B., Yadav D. et al. // Int. J. Pharm. Tech. Res. – 2014. – Vol. 6, №4. – Р. 1245-1255.
Mahmoud M.R., Abou-Elmagd W.S.I., El-Shahawi M.M., Hekal M.H. // Eur. Chem. Bull. – 2014. – Vol. 3, №7. – Р. 723-728.
Murti Y., Agnihotri R., Pathak D. // Amer. J. Chem. – 2011. – Vol. 1, №2. – Р. 42-46.
Patel G.K., Patel H.S. // Int. J. Res. Pharm. Chem. – 2014. – Vol. 4, №4. – Р. 928-935.
Poroikov V.V. // Med. Chem. Res. – 2010. – Vol. 19 (S1). – S. 30.
Saidov N.B., Georgiyants V.A., Garna N.V. // ЖОФХ. – 2013. – Т. 11, №4(44). – С. 33-37.
Saidov N.B., Kadamov I.M., Georgiyants V.A. // Вісник фармації. – 2012. – №4(72). – С. 22-26.
Saidov N.B., Kadamov I.M., Georgiyants V.A. // ЖОФХ. – 2012. – Т. 10, вип. 4(40). – С. 25-28.
Saidov N.B., Kadamov I.M., Georgiyants V.A. // ЖОФХ. – 2013. – T. 11, №1(41). – С. 44-48.
Shoemaker R.H. // Nat. Rev. Cancer. – 2006. – Vol. 6, №8. – Р. 813-823.
Downloads
Published
Issue
Section
License
Copyright (c) 2015 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).